XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

and tolerability of serum uric acid lowering and maintenance with febuxostat in patients with gout. Febuxostat Open-label Clinical Trial of Urate-lowering Efficacy and Safety Adverse events were ...

A groundbreaking study presented at the Radiological Society of North America annual meeting has revealed troubling findings about levothyroxine, a medication used by approximately 23 million ...

Diet to keep high uric acid levels in check (Freepik, representational image) Gout is a form of arthritis characterised by sudden and severe pain, redness, and swelling in the joints, often caused ...

Achieving serum urate to below 6 mg/dL with urate-lowering therapy (ULT) in patients with gout and chronic kidney disease (CKD) stage III is not linked to an increased risk for severe or end-stage ...